Effect of Dexmedetomidine on Postoperative Delirium After Awake Craniotomies

NARecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
DexmedetomidineDeliriumAwake Craniotomy
Interventions
DRUG

Dexmedetomidine

The 200ug dexmedetomidine will be diluted into a 50ml syringe and administered with continuous infusion at a rate of 0.2 µg/kg/hour until the end of dural closure.

DRUG

0.9% saline

The 0.9% saline is administered with the same volume at the same speed as the other group.

Trial Locations (1)

100160

RECRUITING

Beijing Tian Tan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER